Wei Jingjing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Jingjing has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Kaibinuer Aierken
Tumor Hospital of Xinjiang Medical University
2 shared publicationsKaibinuer Tuoheti
Department of Epidemiology and Biostatistics, School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, China
2 shared publications- Peierdun Mijiti
Department of Epidemiology and Biostatistics, School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, China
2 shared publications Qi Shuang
Department of Epidemiology and Biostatistics, School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, China
2 shared publicationsSulaiman Muhetaer
Sixth Affiliated Hospital of Xinjiang Medical University
2 shared publicationsYe Lixia
Department of Epidemiology and Biostatistics, School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, China
2 shared publications
Latest Publications
- Open Access
- 11 December 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1697528
DEG-BRIN-GCN: interpretable graph convolutional framework with differentially expressed genes brain region interaction network prior for AD diagnosis
Due to the intricate dynamic coupling between molecular networks and brain regions, early diagnosis and pathological mechanism analysis of Alzheimer's disease (AD) remain highly challenging. To address this, we propose a graph convolutional neural network framework (DEG-BRIN-GCN) based on a differentially expressed gene-brain region interaction network (DEG-BRIN), aiming to enhance both diagnostic accuracy and biological interpretability in AD research. We began by systematically analyzing transcriptomic data from 19 brain regions, identifying 329 differentially expressed genes that display widespread co-expression across multiple regions. Using these findings, we constructed DEG-BRIN to model prior associations among genes, thereby revealing potential molecular connectivity patterns implicated in AD pathological progression. Leveraging this network prior, we developed an AD classification model based on graph convolutional networks. Comparative experiments demonstrate that our proposed DEG-BRIN-GCN achieves significantly better diagnostic performance than three categories of baseline models: traditional machine learning methods, Random-GCN (models based on random network topologies), and PPI-GCN. Further analysis identified key brain regions–such as the superior parietal lobule, putamen, and frontal pole–along with high-contribution genes, including VCAM1, MCTP1, HBB, and CX3CR1, which play critical roles in AD pathology. Notably, this study is the first to implement a interpretability analysis based on a “gene-region-pathway” triad, offering a novel framework for cross-scale exploration of AD pathological mechanisms. Our findings underscore the central importance of inter-regional molecular interaction networks in the accurate diagnosis of AD.
- 11 December 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1697528
Open AccessDEG-BRIN-GCN: interpretable graph convolutional framework with differentially expressed genes brain region interaction network prior for AD diagnosis
Due to the intricate dynamic coupling between molecular networks and brain regions, early diagnosis and pathological mechanism analysis of Alzheimer's disease (AD) remain highly challenging. To address this, we propose a graph convolutional neural network framework (DEG-BRIN-GCN) based on a differentially expressed gene-brain region interaction network (DEG-BRIN), aiming to enhance both diagnostic accuracy and biological interpretability in AD research. We began by systematically analyzing transcriptomic data from 19 brain regions, identifying 329 differentially expressed genes that display widespread co-expression across multiple regions. Using these findings, we constructed DEG-BRIN to model prior associations among genes, thereby revealing potential molecular connectivity patterns implicated in AD pathological progression. Leveraging this network prior, we developed an AD classification model based on graph convolutional networks. Comparative experiments demonstrate that our proposed DEG-BRIN-GCN achieves significantly better diagnostic performance than three categories of baseline models: traditional machine learning methods, Random-GCN (models based on random network topologies), and PPI-GCN. Further analysis identified key brain regions–such as the superior parietal lobule, putamen, and frontal pole–along with high-contribution genes, including VCAM1, MCTP1, HBB, and CX3CR1, which play critical roles in AD pathology. Notably, this study is the first to implement a interpretability analysis based on a “gene-region-pathway” triad, offering a novel framework for cross-scale exploration of AD pathological mechanisms. Our findings underscore the central importance of inter-regional molecular interaction networks in the accurate diagnosis of AD.
- Open Access
- 9 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Trends in the disease burden of cystic echinococcosis in China, 1990–2044 analysis and forecasting study
This study aims to analyze changes in the disease burden of cystic echinococcosis in China from 1990 to 2019 and to predict trends from 2020 to 2044. Using the Global Burden of Disease 2019 (GBD 2019) database, we analyzed the trends in annual percentage change (APC) and average annual percentage change (AAPC) for incidence, prevalence, death, and disability-adjusted life years (DALY) rates of cystic echinococcosis in China via the Joinpoint Regression Program 4.8.0.1 software. Additionally, we applied Nordpred modeling to predict future trends in disease burden over the next 25 years. From 1990 to 2019, the incidence and prevalence of cystic echinococcosis in the Chinese population showed an overall increasing trend, whereas the death and DALY rates exhibited an overall decreasing trend. The disease burden of cystic echinococcosis was greater in males than in females, with significant differences across age groups. The highest incidence and prevalence rates were observed in the 10–24 years age group, whereas the lowest occurred in the 0–9 years age group. Fatalities and DALY rates increased with age, particularly in the 70 and older age groups. According to the Nordpred modeling results, the incidence, prevalence, and DALY rates of cystic echinococcosis in China are expected to rise slightly over the next 25 years. The overall disease burden of cystic echinococcosis is projected to increase gradually between 2020 and 2044, with men exhibiting higher incidence, prevalence, and DALY rates than women.
- 9 February 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessTrends in the disease burden of cystic echinococcosis in China, 1990–2044 analysis and forecasting study
This study aims to analyze changes in the disease burden of cystic echinococcosis in China from 1990 to 2019 and to predict trends from 2020 to 2044. Using the Global Burden of Disease 2019 (GBD 2019) database, we analyzed the trends in annual percentage change (APC) and average annual percentage change (AAPC) for incidence, prevalence, death, and disability-adjusted life years (DALY) rates of cystic echinococcosis in China via the Joinpoint Regression Program 4.8.0.1 software. Additionally, we applied Nordpred modeling to predict future trends in disease burden over the next 25 years. From 1990 to 2019, the incidence and prevalence of cystic echinococcosis in the Chinese population showed an overall increasing trend, whereas the death and DALY rates exhibited an overall decreasing trend. The disease burden of cystic echinococcosis was greater in males than in females, with significant differences across age groups. The highest incidence and prevalence rates were observed in the 10–24 years age group, whereas the lowest occurred in the 0–9 years age group. Fatalities and DALY rates increased with age, particularly in the 70 and older age groups. According to the Nordpred modeling results, the incidence, prevalence, and DALY rates of cystic echinococcosis in China are expected to rise slightly over the next 25 years. The overall disease burden of cystic echinococcosis is projected to increase gradually between 2020 and 2044, with men exhibiting higher incidence, prevalence, and DALY rates than women.
- Open Access
- 23 January 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1504481
Trends in incidence, mortality, and DALYs of cystic echinococcosis in Central Asia from 1992 to 2021: an age-period-cohort analysis
Background: Cystic echinococcosis (CE) is widespread globally but imposes a particularly heavy burden in Central Asia. Despite control measures, disease management remains suboptimal in this region. This study analyzed trends in CE incidence, mortality, and disability-adjusted life years (DALYs) from 1992 to 2021 in Central Asia; compared them with global data; and explored variations by gender, age group, and country to identify critical factors in disease control.Methods: Using data from the Global Burden of Disease Study 2021 (GBD 2021), we analyzed long-term trends in the incidence, mortality, and DALY rates of CE in Central Asia. The joinpoint regression model was employed to calculate the annual percentage change (APC) and average APC (AAPC) to identify shifts in disease trends. Additionally, an age-period-cohort model was used to assess the impact of various age groups, periods, and birth cohorts on the disease burden.Results: The number of CE cases increased by 52.13% in Central Asia, while deaths decreased by 57.35%; DALYs decreased only slightly by 10.75%. From 1992 to 2021, CE incidence showed an increasing trend until 2010, then rapidly declined until 2015, and then gradually increased thereafter. The highest incidence rates were among middle-aged and older adult populations. Although mortality and DALY rates decreased across all age groups, the decline was less than the global trend. Gender analysis showed that the incidence rate was significantly higher in males than in females.Conclusion: Although there have been improvements in the CE disease burden in some Central Asian countries, the overall burden remains significant. This study highlights the importance of considering gender, age, and country-specific disease burdens when formulating public health policies. Future research should continue to monitor these trends and explore targeted prevention strategies within diverse socioeconomic contexts, such as integrating regional socioeconomic factors and public health resources.
- 23 January 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 12, 1504481
Open AccessTrends in incidence, mortality, and DALYs of cystic echinococcosis in Central Asia from 1992 to 2021: an age-period-cohort analysis
Background: Cystic echinococcosis (CE) is widespread globally but imposes a particularly heavy burden in Central Asia. Despite control measures, disease management remains suboptimal in this region. This study analyzed trends in CE incidence, mortality, and disability-adjusted life years (DALYs) from 1992 to 2021 in Central Asia; compared them with global data; and explored variations by gender, age group, and country to identify critical factors in disease control.Methods: Using data from the Global Burden of Disease Study 2021 (GBD 2021), we analyzed long-term trends in the incidence, mortality, and DALY rates of CE in Central Asia. The joinpoint regression model was employed to calculate the annual percentage change (APC) and average APC (AAPC) to identify shifts in disease trends. Additionally, an age-period-cohort model was used to assess the impact of various age groups, periods, and birth cohorts on the disease burden.Results: The number of CE cases increased by 52.13% in Central Asia, while deaths decreased by 57.35%; DALYs decreased only slightly by 10.75%. From 1992 to 2021, CE incidence showed an increasing trend until 2010, then rapidly declined until 2015, and then gradually increased thereafter. The highest incidence rates were among middle-aged and older adult populations. Although mortality and DALY rates decreased across all age groups, the decline was less than the global trend. Gender analysis showed that the incidence rate was significantly higher in males than in females.Conclusion: Although there have been improvements in the CE disease burden in some Central Asian countries, the overall burden remains significant. This study highlights the importance of considering gender, age, and country-specific disease burdens when formulating public health policies. Future research should continue to monitor these trends and explore targeted prevention strategies within diverse socioeconomic contexts, such as integrating regional socioeconomic factors and public health resources.
- Open Access
- 17 October 2024
- Published by Springer Nature in Research Square
Symptom networks of multidimensional symptom experiences in breast cancer survivors: A network analysis
Objectives We aimed to construct a symptom network for breast cancer patients, identify its core symptoms, and explore symptom clusters. This network approach may provide valuable insights for precise interventions to improve the overall quality of life in breast cancer patients. Methods A total of 462 eligible breast cancer patients were recruited. The severity of patients' symptoms was measured using the EORTC QLQ-C30 Chinese version scale and Zung Self-Rating Depression and Anxiety Scale. A regularized partial correlation network was established, and central symptoms were identified using Strength centrality. Results The strongest associations were observed between NV-AP (weight = 0.39), Dep-Anx (weight = 0.38), PA-DY (weight = 0.21), and Anx-SL (weight = 0.20). Fatigue was the most prevalent symptom among breast cancer patients, and fatigue was consistently the central symptom in the network, in addition to anxiety, appitie loss, and pain. DAG indicated that fatigue might influence overall symptoms in breast cancer patients. Three syomtom clusters were indentified: emotional symptoms (depression, anxiety, and insomnia), gastrointestinal symptoms (nausea/vomiting, diarrhea, and loss of appetite), and somatic symptoms (fatigue, pain, and dyspnea). Conclusions Fatigue, depression, and anxiety are highly prevalent and central symptoms in breast cancer patients. It is crucial to screen and provide early treatment for these symptoms to effectively manage them and enhance the overall quality of life for breast cancer patients. Future studies should focus on conducting longitudinal research to establish dynamic networks and investigate causal relationships between these symptoms.
- 17 October 2024
- Published by Springer Nature in Research Square
Open AccessSymptom networks of multidimensional symptom experiences in breast cancer survivors: A network analysis
Objectives We aimed to construct a symptom network for breast cancer patients, identify its core symptoms, and explore symptom clusters. This network approach may provide valuable insights for precise interventions to improve the overall quality of life in breast cancer patients. Methods A total of 462 eligible breast cancer patients were recruited. The severity of patients' symptoms was measured using the EORTC QLQ-C30 Chinese version scale and Zung Self-Rating Depression and Anxiety Scale. A regularized partial correlation network was established, and central symptoms were identified using Strength centrality. Results The strongest associations were observed between NV-AP (weight = 0.39), Dep-Anx (weight = 0.38), PA-DY (weight = 0.21), and Anx-SL (weight = 0.20). Fatigue was the most prevalent symptom among breast cancer patients, and fatigue was consistently the central symptom in the network, in addition to anxiety, appitie loss, and pain. DAG indicated that fatigue might influence overall symptoms in breast cancer patients. Three syomtom clusters were indentified: emotional symptoms (depression, anxiety, and insomnia), gastrointestinal symptoms (nausea/vomiting, diarrhea, and loss of appetite), and somatic symptoms (fatigue, pain, and dyspnea). Conclusions Fatigue, depression, and anxiety are highly prevalent and central symptoms in breast cancer patients. It is crucial to screen and provide early treatment for these symptoms to effectively manage them and enhance the overall quality of life for breast cancer patients. Future studies should focus on conducting longitudinal research to establish dynamic networks and investigate causal relationships between these symptoms.
- Open Access
- 23 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1325986
A network approach to investigating the inter-relationship between health-related quality of life dimensions and depression in 1735 Chinese patients with heterogeneous cancers
Background: We aimed to explore the inter-connection between depression and HRQOL dimensions in cancer patients using a network approach, which might provide new insights for precise interventions to improve cancer patients’ overall HRQOL.Methods: Between June 1, 2016, and August 31, 2017, a total of 1735 eligible patients with heterogeneous types of cancer were recruited. The Zung Self-Rating Depression Scale (SDS) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) were used to measure patients’ depression status and HRQOL, respectively. A regularized partial correlation network was established. Central and bridge symptoms/functions were identified using expected influence and bridge expected influence. A directed acyclic graph (DAG) was used to explore the possible causal relationship between depression and HRQOL dimensions.Results: In this study, depression and 15 dimensions of the EORTC-QLQ-C30 scale were highly inter-correlated and could be represented as a network. We found that nearly two-thirds of cancer patients experienced various degrees of depression, and depression was consistently the central symptom in the network, in addition to nausea/vomiting, pain, and physical function. DAG and bridge symptoms indicated that depression might influence overall HRQOL in cancer patients mainly through emotional function, pain, physical function, and sleeplessness, particularly in cancer patients with moderate-to-severe depression. The disparity in network structures between mild and moderate-to-severe depression suggested that the relationship between depression and HRQOL dimensions might be bidirectional.Conclusion: The prevalence of depression remained high in Chinese patients with cancer, and depression may influence various symptoms and functions within the HRQOL network. Screening and early treatment of depression were warranted to improve the overall HRQOL of cancer patients, in addition to adequate treatment of pain and nausea/vomiting and improvement in physical function.
- 23 January 2024
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 11, 1325986
Open AccessA network approach to investigating the inter-relationship between health-related quality of life dimensions and depression in 1735 Chinese patients with heterogeneous cancers
Background: We aimed to explore the inter-connection between depression and HRQOL dimensions in cancer patients using a network approach, which might provide new insights for precise interventions to improve cancer patients’ overall HRQOL.Methods: Between June 1, 2016, and August 31, 2017, a total of 1735 eligible patients with heterogeneous types of cancer were recruited. The Zung Self-Rating Depression Scale (SDS) and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) were used to measure patients’ depression status and HRQOL, respectively. A regularized partial correlation network was established. Central and bridge symptoms/functions were identified using expected influence and bridge expected influence. A directed acyclic graph (DAG) was used to explore the possible causal relationship between depression and HRQOL dimensions.Results: In this study, depression and 15 dimensions of the EORTC-QLQ-C30 scale were highly inter-correlated and could be represented as a network. We found that nearly two-thirds of cancer patients experienced various degrees of depression, and depression was consistently the central symptom in the network, in addition to nausea/vomiting, pain, and physical function. DAG and bridge symptoms indicated that depression might influence overall HRQOL in cancer patients mainly through emotional function, pain, physical function, and sleeplessness, particularly in cancer patients with moderate-to-severe depression. The disparity in network structures between mild and moderate-to-severe depression suggested that the relationship between depression and HRQOL dimensions might be bidirectional.Conclusion: The prevalence of depression remained high in Chinese patients with cancer, and depression may influence various symptoms and functions within the HRQOL network. Screening and early treatment of depression were warranted to improve the overall HRQOL of cancer patients, in addition to adequate treatment of pain and nausea/vomiting and improvement in physical function.